The Intelligence from The Economist Arms within reach: Israel's vaccination lead
Jan 4, 2021
Anshul Pfeffer, The Economist's Israel correspondent, shares insights into Israel's world-leading vaccination efforts, emphasizing the blend of logistics and political strategy. He discusses how Prime Minister Netanyahu's leadership ties the vaccination campaign to the electoral landscape. Meanwhile, Charlotte Howard, the energy and commodities editor, examines the struggles of major oil companies in a shifting energy climate, analyzing the financial downturn and the pressures of climate accountability. The conversation wraps with a nod to the revival of nightlife in post-pandemic China, showcasing local talent.
AI Snips
Chapters
Transcript
Episode notes
Israel's Vaccination Lead
- Israel's vaccination rate is much higher than Britain's and America's.
- Israel has vaccinated 13% of its population, while Britain and the US have vaccinated less than 1.5% and 1%, respectively.
Reasons for Israel's Success
- Israel's small size simplifies vaccination logistics.
- The country's four competing HMOs drive efficient rollout through competition.
Securing Vaccine Doses
- Israel paid a premium, possibly double other countries, for early access to the Pfizer vaccine.
- This decision aimed to liberate the economy from coronavirus quickly.